Trademark Alertz ®
Search
Trademark
Owner
Trademark: OXFORD BIOMEDICA 2095512
Word
OXFORD BIOMEDICA
ID
2095512
Trademark Type
Word
Status
Registered: Registered/protected
Application Date
12 June 2020
Registration Date
12 June 2020
Renewal Date
12 June 2030
Owner(s)
Oxford BioMedica Plc a United Kingdom company
Service
Spruson & Ferguson
Goods and Services:
Class 5
:
Therapeutic and prophylactic pharmaceutical products
;
gene therapy products
;
vaccines
;
pharmaceuticals in the form of nanoparticles for delivery
;
pharmaceutical substances and preparations
;
pharmaceutical substances and preparations, nanoparticals, viral vectors, retroviral vectors, lentiviral vectors and non-viral vectors for the delivery of genes to cells, all for medical purposes
;
vaccine manufacturing preparations
;
viral vector, retroviral vector, lentiviral vector and non-viral vector manufacturing preparations
;
biochemical and chemical products for use in medical science
;
pharmaceutical and biochemical preparations for the treatment or prevention of cancer, infectious disease, fungal diseases, disease caused by parasites, eye disease, diseases of the central and peripheral nervous systems, cardiovascular disease, diseases affecting the immune system, inflammatory diseases, inherited disease, single gene disorders, diseases of the mouth, teeth, skin, hair and ear, bone and blood diseases and reproductive system disorders
;
pharmaceutical and biochemical preparations for contraceptive purposes.
Class 40
:
Custom manufacture of products relating to biotechnology
;
manufacture of gene therapy, and viral, retroviral, lentiviral and non-viral preparations and biopharmaceutical products
;
biotechnology contract manufacturing services
;
contract manufacturing of viral and non-viral vectors
;
manufacture of vaccines.
Class 42
:
Research and laboratory analytic and diagnostic services
;
design of manufacturing facilities
;
quality control and validation services
;
Product development consultancy in the field of nanotechnology, gene therapy and vector-based delivery systems
;
product, viral vector and analytic assay development for others
;
laboratory services
;
research and development services
;
genetic engineering laboratories and biochemistry laboratories
;
scientific and technological services and research
;
industrial analysis services
;
provision of information relating to scientific research
;
provision of scientific information
;
research and scientific analysis relating to drug discovery and development for others
;
scientific advisory services
;
scientific consultancy
;
scientific research and development
;
scientific research in the field of biotechnology and pharmaceuticals
;
management of scientific research projects
;
issuing of scientific information
;
advisory services relating to scientific and clinical research
;
biological research, clinical research and medical research
;
clinical research
;
conducting clinical trials
;
manufacturing and manufacturing development services
;
regulatory advice relating to chemistry manufacturing and controls (CMC) activities.
Class 44
:
Medical diagnostic services
;
information relating to pharmaceuticals, bioceuticals and advanced therapy medicinal products
;
writing reports on pharmaceuticals, bioceuticals and advanced therapy medicinal products
;
preparation of medical reports
;
consultancy, advice and information in the field of clinical trials, healthcare, pharmaceuticals and advanced therapy medicinal products
;
advisory services relating to vaccination regimes
;
advisory services relating to the treatment, relief and/or prevention of cancer, infectious diseases, fungal diseases, disease caused by parasites, eye disease, diseases of the central and peripheral nervous systems, cardiovascular disease, diseases affecting the immune system, inflammatory diseases, inherited disease, single gene disorders, diseases of the mouth, teeth, skin, hair and ear, bone and blood diseases, reproductive system disorders, and pharmaceutical and biochemical preparations for contraceptive purposes, in humans and animals
;
preparation and review of reports for regulatory approval of pharmaceuticals and bioceuticals
;
information, consultancy and advice relating to regulatory approval of advanced therapy medicinal products
;
consultancy, advice and information in the field of drug regulatory approval (medical advice).
Class 45
:
Licensing and management of intellectual property.